Cx3cr1, the receptor for the chemokine Cx3cl1 (fractalkine), has been implicated in the progression and severity of Alzheimer’s disease-like pathology in mice, but the underlying mechanisms remain unclear. Here, CX3CL1 is linked to early-onset autosomal dominant Alzheimer disease.